LY364947

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP05350CAS No. ：396129-53-6Purity：98%

Get Quotation Now

Tel: 0086-13026320035 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	396129-53-6	Cat. No.	BCP05350
Name	LY364947
Synonyms	LY-364947;LY 364947;
SMILES
Chemical Name
Formula	C17H12N4	M. Wt	272.3
Purity	98%	Storage	Store at 4-8°C
Description	in vitro: LY364947 is an ATP competitive and tight-binding inhibitor, inhibiting phosphorylation of P-Smad3 by TGFβR-I kinase with Ki of 28 nM. LY364947 inhibits in vivo Smad2 phosphorylation within the NMuMg cells with IC50 of 135 nM. LY364947 reverses TGF-β-mediated growth inhibition in NMuMg cells with IC50 of 0.218 μM. LY364947 potentiates the xVent2-lux BMP4 response in NMuMg cells by 30% at concentrations as low as 0.25 μM. LY364947 (2 μM) prevents TGF-β-induced epithelial-mesenchymal transition in NMuMg cells . LY364947 (3 μM) induces expression of Prox1 and LYVE-1 in almost all HDLECs after 24 hours . LY364947 promotes nuclear export of Foxo3a, with low Smad2/3 and high Akt phosphorylation levels in leukaemia-initiating cells. LY364947 (< 20 μM) suppresses leukaemia-initiating cells colony-forming ability after co-culture with OP-9 stromal cells. in vivo: LY364947 (1 mg/kg i.p.) accelerates lymphangiogenesis, as evidence by significantly increased the LYVE-1-positive areas, in